Stanford University researchers used artificial intelligence to create 16 [1] synthetic viruses that target drug-resistant bacteria.
This development provides a potential new weapon against antibiotic-resistant infections, which often evade traditional medical treatments. By designing viruses from scratch, scientists may be able to create custom tools to eliminate specific bacterial strains that are otherwise untreatable.
The team, including senior author Thomas Inglesby and co-author Moritz S. Hanke, developed bacteriophages that do not exist in nature [1]. These AI-designed viruses can be reproduced in a laboratory setting to attack pathogens [2]. The research was published this month in the peer-reviewed journal Science [1].
"We have shown that artificial intelligence can design functional bacteriophages that kill drug-resistant bacteria in the lab," Inglesby said.
While the ability to engineer pathogens offers medical promise, it also introduces risks. Hanke said that designing viruses from scratch could open a new frontier in the fight against superbugs, but it also raises serious biosecurity concerns.
Some experts warn that the technology could be misused if not strictly regulated. James Collins said these computer-made pathogens pose urgent biosafety questions that the scientific community must address before they are widely deployed.
The project represents a shift from discovering viruses in the wild to engineering them for specific clinical needs. The AI models allowed the team to bypass the traditional search for naturally occurring phages—a process that is often slow and unpredictable [3].
“Artificial intelligence can design functional bacteriophages that kill drug-resistant bacteria in the lab.”
The ability to synthetically generate viable viruses marks a transition toward precision antimicrobial therapy. While this could solve the crisis of antibiotic resistance by creating 'designer' killers for specific bacteria, it creates a dual-use dilemma where the same AI tools used for medicine could theoretically be used to create harmful pathogens, necessitating new international biosecurity frameworks.
